1-3 of 3
Michael R. Christie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IA-2 Antibody-Negative Status Predicts Remission and Recovery of C-Peptide Levels in Type 1 Diabetic Patients Treated With Cyclosporin

Michael R. Christie, PhD, Jens Mølvig, Charlotte J. Hawkes, PhD, Bendix Carstensen, Thomas Mandrup-Poulsen, the Canadian-European Randomised Control Trial Group
Journal: Diabetes Care
Diabetes Care 2002;25(7):1192–1197
https://doi.org/10.2337/diacare.25.7.1192
Published: 01 July 2002
View article titled, IA-2 Antibody-Negative Status Predicts Remission and Recovery of C-Peptide Levels in Type 1 Diabetic Patients Treated With Cyclosporin
Open the PDF for IA-2 Antibody-Negative Status Predicts Remission and Recovery of C-Peptide Levels in Type 1 Diabetic Patients Treated With Cyclosporin in another window
Journal Articles

Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane–Associated Antigen in (Pre)type 1 Diabetes: Association with IA-2 and islet cell autoantibodies

Frederic Winnock, PHARM, Michael R. Christie, PHD, Manou R. Batstra, PHD, Henk-Jan Aanstoot, MD, PHD, Ilse Weets, MD, Katelijn Decochez, MD, Philippe Jopart, MD, Dany Nicolaij, MD, Frans K. Gorus, MD, PHD, The Belgian Diabetes Registry
Journal: Diabetes Care
Diabetes Care 2001;24(7):1181–1186
https://doi.org/10.2337/diacare.24.7.1181
Published: 01 July 2001
View article titled, Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane–Associated Antigen in (Pre)type 1 Diabetes: <subtitle>Association with IA-2 and islet cell autoantibodies</subtitle>
Open the PDF for Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane–Associated Antigen in (Pre)type 1 Diabetes: <subtitle>Association with IA-2 and islet cell autoantibodies</subtitle> in another window
Journal Articles

Validity of Screening for Individuals at Risk for Type I Diabetes by Combined Analysis of Antibodies to Recombinant Proteins

Michael R Christie, PHD, Ursula Roll, PHD, Mark A Payton, PHD, Emma CI Hatfield, MCCP, Anette-G Ziegler, MD
Journal: Diabetes Care
Diabetes Care 1997;20(6):965–970
https://doi.org/10.2337/diacare.20.6.965
Published: 01 June 1997
View article titled, Validity of Screening for Individuals at Risk for Type I Diabetes by Combined Analysis of Antibodies to Recombinant Proteins
Open the PDF for Validity of Screening for Individuals at Risk for Type I Diabetes by Combined Analysis of Antibodies to Recombinant Proteins in another window